Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Cisplatin 7Cetuximab 6Radiotherapy 5Fluorouracil 4Radiotherapy, Intensity-Modulated 3Docetaxel 3pembrolizumab 2Radiation 2Psychiatric Rehabilitation 2Nicotine 2Hydroxyurea 2Drug Therapy 2Counseling 2Celecoxib 2Bupropion 2sodium thiosulfate 1sargramostim 1motexafin gadolinium 1eniluracil 1durvalumab 1Zinc Oxide 1Varenicline 1Tobacco Use Cessation Devices 1Surgical Procedures, Operative 1Semaxinib 1Referral and Consultation 1Protons 1Proton Therapy 1Polymerase Chain Reaction 1Pilocarpine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypopharyngeal Neoplasms × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT03258554 2026-06-02

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 2/3 Completed
196 enrolled 31 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡